Blended Solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Observations in outsourcing: Survey results show a blended future
Discover the trends in modern clinical development outsourcing across biopharmaceutical organisations.
.jpeg?crop=yes&w=310&h=310&itok=YMmk-FAd "blended_solutions_woman_looking_at_laptop"){kind=icon}
Whitepaper: Embracing a blended operating model
Outsourcing encompasses more than half the total global clinical development spend. As a result, the way the industry outsources is evolving to maximise ROI and efficiency amid increasing complexity and difficulty within the clinical development landscape.
Whitepaper: How investments in supply of CRAs is better than competing with the demand for CRAs
In this whitepaper, 91黑料’s experts address our commitment to four main objectives to reducing the CRA drought.
Whitepaper: The evolution of FSP, not just for large pharma
For mid-size pharma, CRO and FSP models may evolve as the company grows. This either/or decision often means switching models by switching suppliers. By harnessing the ‘Embedded Blended’ model, all sponsors can benefit from a synchronised outsourcing strategy.
Whitepaper: Clinical trials in Japan: An enterprise growth and management strategy
Presenting a unique approach to evolve the traditional local clinical development model in Japan, while lowering costs, improving productivity, and potentially accelerating drug approval timelines.
Media contributions
Blogs
-
Blog: Best practices for KPI management in FSP partnerships
Learn more about the best practices for KPI creation and management in this blog.
-
Blog: Redefining sourcing model terminology
As clinical development services and outsourcing models have become more complex, we have outgrown old definitions these models. This blog explores the new framework for defining CRO sourcing models and explains its importance.
-
Blog: How joint venture models can boost Japan’s pharmaceutical industry
Japan is the third-largest consumer of ethical drugs and the world’s third-largest economy; therefore, it is an important development centre for new medicines. However, there are various cultural and economic challenges in Japan that make it difficult to manage a fixed workforce against a variable portfolio of clinical research.
Blended Solutions
91黑料 provides blended solutions with custom configurations to address sponsor challenges through seamlessly integrated service delivery. 91黑料 combines world-leading global FSP solutions, FSO, standalone, and specialty services for efficiency and control. Expert consultants guide transitions and use formal governance to optimize the benefits of a bespoke, flexible, and efficient model.